What turns on the endothelins?

Inflammation Research

Volumn 45, Issue 2, 1996, Pages 51-53

  Warner, T D ^a   Klemm, P ^b  

^a ST BARTHOLOMEW S HOSPITAL   (United Kingdom)

^b SANOFI   (France)

Author keywords

Adjuvant arthritis; Endothelin 1 cytokines; Inflammatory vasoconstriction

Indexed keywords

CYTOKINE; ENDOTHELIN 1; ENDOTHELIN RECEPTOR ANTAGONIST; INTERLEUKIN 2; TUMOR NECROSIS FACTOR ALPHA; VASOCONSTRICTOR AGENT;

CIRCULATION; CONGESTIVE HEART FAILURE; CORONARY ARTERY BLOOD FLOW; CORONARY ARTERY CONSTRICTION; HUMAN; INFLAMMATION; ISCHEMIA; NONHUMAN; POLYARTHRITIS; PROTEIN EXPRESSION; SEPTIC SHOCK; SHORT SURVEY; TRANSCRIPTION REGULATION; VASCULAR ENDOTHELIUM; VASCULITIS;

ANIMALS; CYTOKINES; ENDOTHELINS; HUMANS; INFLAMMATION; VASOCONSTRICTION;

EID: 0030041401     PISSN: 10233830     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02265115     Document Type: Short Survey

References (22)

1. Rubanyi GM, Polokoff MA. Endothelins: molecular biology, biochemistry, pharmacology, physiology and pathophysiology. Pharmacol Rev 1994;46:325-415.
2. Warner TD, Battistini B, Doherty AM, Corder R. Endothelin receptor antagonists: actions and rationale for their development. Biochem Pharmacol 1994;48:625-35.
3. Warner TD. Endothelin receptor antagonists. Pharmacol Drug Rev 1994;12:105-22.
4. Kiowski W, Sütsch G, Hunziker P, Müller P, Kim J, Oechslin E. Evidence for endothelin-1-mediated vasoconstriction in severe chronic heart failure. Lancet 1995;346:732-6.
5. Haynes WG, Webb DJ. Contribution of endogenous generation of endothelin-1 to basal vascular tone. Lancet 1994;344:852-4.
6. Vemulapalli S, Chiu PJS, Griscti K, Brown A, Kurowski S, Sybertz E. Phosphoramidon does not inhibit endogenous endothelin-1 release stimulated by hemorrhage, cytokines and hypoxia in rats. Eur J Pharmacol 1994;257:95-102.
7. Klemm P, Warner TD, Hohlfeld T, Corder R, Vane JR. Endothelin 1 mediates ex vivo coronary vasoconstriction caused by exogenous and endogenous cytokines. Proc Natl Acad Sci USA 1995;92:2691-5.
8. Heller RA, Krönke M. Tumor necrosis factor receptor-mediated signaling pathways. J Cell Biol 1994;126:5-9.
9. Arai K, Lee F, Miyajima A, Miyatake S, Arai N, Yokota T. Cytokines: coordinators of immune and inflammatory responses. Ann Rev Biochem 1990;59:783-94.
10. Arend WP, Dayer JM. Cytokines and cytokine inhibitors or antagonists in rheumatoid arthritis. Arthr Rheum 1990;33:305-15.
11. Klemm P, Warner TD, Willis D, Moore AR, Vane JR. Coronary vasoconstriction in vitro in the hearts of polyarthritic rats: effectiveness of in vivo treatment with the endothelin receptor antagonist SB 209670. Br J Pharmacol 1995;114:1327-8.
12. Baydoun AR, Peers SH, Cirino G, Woodward B. Effects of endothelin-1 on the rat isolated heart. J Cardiovasc Pharmacol 1989;13 Suppl 5:S193-6.
13. Warner TD. Endothelin receptor antagonists. Cardiovasc Drug Rev 1994;12:105-22.
14. Nose PS. Cytokines and reperfusion injury. J Cardiac Surg 1993;8 Suppl 2:305-8.
15. Stenbergh WC, Tuttle TM, Makhoul RG, Bear HD, Sobel M, Fowler AA. Postischemic extremities exhibit immediate release of tumor necrosis factor. J Vasc Surg 1994;20:474-81.
16. Liu T, Clark RK, McDonnell PC, Young PR, White RF, Barone FC, et al. Tumor necrosis factor-alpha expression in ischemic neurons. Stroke 1994;25:1481-8.
17. Robertson CR, McCallum RM. Changing concepts in the pathophysiology of vasculitides. Curr Opinion Rheumatol 1994;6:3-10.
18. Savage CO, Cooke SP. The role of the endothelium in systemic vasculitis. J Autoimmun 1993;6:237-49.
19. Mann DL, Young JB. Basic mechanisms in congestive heart failure. Recognizing the role of proinflammatory cytokines. Chest 1994;105:897-904.
20. Hennig B, Diana JN, Toborek M, McClain CJ. Influence of nutrients and cytokines on endothelial cell metabolism. J Am Coll Nutr 1994;13:224-31.
21. Stricter RM, Kunkel SL, Bone RC. Role of tumor necrosis factor-α in disease states and inflammation. Crit Care Med 1993;21 Suppl 10:S447-63.
22. Gardiner SM, Kemp PA, March JE, Bennett T. Enhancement of the hypotensive and vasodilator effects of endotoxaemia in conscious rats by the endothelin antagonist, SB 209670. Br J Pharmacol 1995;116:1718-9.